An analysis of non ST-elevation myocardial infarction (NSTEMI) patients who undergo coronary revascularization within 24 hours of hospitalization showed an increased reduction in mortality, marking the first time this difference has been demonstrated. Results from “Outcomes of Early vs. Late Revascularization in Low and High-Risk Patients Hospitalized with Non-ST-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Surveillance Study” were presented as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions, May 10-13 in New Orleans.

The Medtronic Micra leadless pacemaker is the smallest pacemaker in the world.
The hooks at the base of the Medtronic Micra leadless pacemaker to anchor it inside the heart. The Micra is the smallest pacemaker in the world.

May 16, 2017 - The preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Registry showed a 99.6 percent implant success rate and a low rate of major complications (1.51 percent) at 30 days in a diverse, real-world patient population. The study was presented in a late-breaking clinical trial session at Heart Rhythm 2017, the Heart Rhythm Society's 38th Annual Scientific Sessions, and simultaneously published in Heart Rhythm.
Medtronic Reveal Linq implantable cardiac monitor. The implanted heart monitor helped identify many high-risk patients with AFib who previously were undiagnosed.

May 16, 2017 - The study using small, subcutaneous implantable cardiac monitors for long-term, 24-hour a day monitoring, detected a high incidence of atrial fibrillation (AF) in patients previously undiagnosed but suspected to be at high-risk for AF and stroke. Data from the REVEAL AF (Incidence of AF in High Risk Patients) study were presented as a late-breaking session at Heart Rhythm 2017, the Heart Rhythm Society's 38th Annual Scientific Sessions. 

May 16, 2017 – A new study examines the effectiveness of the implantable subcutaneous string defibrillator (ISSD), a flexible, string-shaped and first-ever rechargeable implantable cardioverter-defibrillator (ICD). This is the first-in-man study to report on the feasibility of the innovative device and was presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.

Vascular Interventional Advances (VIVA)

The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical success for patients across multiple sites using multiple operators. Results from the PRECISION trial (Efficacy and Safety Outcomes of Radial- vs Femoral-Access Robotic Percutaneous Coronary Intervention: Final Results of the Multicenter PRECISION Registry) were presented as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions, May 10-13 in New Orleans.

Adept Medical announced the launch of the IR Platform, designed as an over-patient work surface for vascular and interventional radiology. The platform provides clinical benefits to the current practice of laying procedural equipment over the patient’s legs by offering a stable, radiolucent, height- and length-appropriate solution for femoral artery access procedures. It offers a stable solution for catheter/guide wire manipulation, with a large work area for equipment.


May 16, 2017 – Results of a groundbreaking clinical trial demonstrate the effectiveness of a novel, fast-acting nasal spray therapy called Etripamil to stop a common rapid heart rate condition known as paroxysmal supraventricular tachycardia (PSVT). The multicenter, randomized trial enrolled of 104 patients from more than 35 centers across the U.S. and Canada and the results were presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now